SPRING 2021
ONCOLOGY Investor
Conference
March 29 - April 2, 2021
CONFERENCE WILL FEATURE A TRACK ON IMMUNOLOGY AND COVID-19 TECHNOLOGIES
250+ Investors
80+ Presenting Companies
10-15 Keynotes and Panels
Virtual Partnering System
One-on-One Meetings
ABOUT THE VIRTUAL ONCOLOGY INVESTOR CONFERENCE
The Spring Meeting of the Oncology Investor Conference will be held from March 29 through April 2, 2021, and feature 4 days of live stream of company presentations and keynote talks, and 5 days of one-on-one meetings. The partnering system will be open for one full month.
The event, sponsored by the National Foundation for Cancer Research, is the preeminent investment event in oncology - for investors seeking to invest in private and public cancer companies, and for cancer related companies seeking investment. The fall and spring meetings have been held every year since 2017.
The Spring 2021 Conference will feature a track on Immunology and COVID-19 Technologies. There will be no other concurrent presentations taking place during the streaming of this track.
The National Foundation for Cancer Research and PharPoint Research are the presenting sponsors. Other Oncology Investor Conference Series sponsors include Perkins Coie, Cooley Law Firm, McDermitt, Will & Emery Law Firm, Venable Law Firm, Freemind Consultants, Torreya Partners and Marcum.
Join the leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, startup public and private cancer companies and cancer foundations for a discussion on trends, opportunities and risks in oncology investing.
PRIOR SPEAKERS
CONFERENCE SPONSORS AND PARTNERS
2020-2021
CRO Sponsors
Oncology-experienced CRO. 95% client repeat rate, industry-best timelines & decentralized capabilities.
Research consultancy that exclusively offers pro bono services to inventors of preclinical stage lung and pancreatic cancer technologies
Sponsors
Presenting Partner
Presenting Sponsor
 |  |  |
|---|